Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5552-5562

  Nazareth, Michael R ^a   Broderick, Lori ^a   Simpson Abelson, Michelle R ^a   Kelleher Jr , Raymond J ^a   Yokota, Sandra J ^a   Bankert, Richard B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD11B ANTIGEN; CD45 ANTIGEN; CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RANTES; SEPRASE; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN EXPRESSION; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON PRODUCTION; LUNG NON SMALL CELL CANCER; LYMPHOCYTE CULTURE; MYOFIBROBLAST; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 34247597310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5552     Document Type: Article

References (71)

1. Jemal, A., T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun. 2005. Cancer statistics. CA Cancer J. Clin. 55: 10-30.
2. Broderick, L., S. P. Brooks, H. Takita, A. N. Baer, J. M. Bernstein, and R. B. Bankert. 2006. IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin. Immunol. 118: 159-169.
3. Zou, W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5: 263-274.
4. Broderick, L. A., and R. B. Bankert. 2006. Membrane-associated TGF-β1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments. J. Immunol. 177: 3082-3088.
5. Hsieh, C. L., D. S. Chen, and L. H. Hwang. 2000. Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum. Gene Ther. 11: 681-692.
6. Halliday, G. M., and S. Le. 2001. Transforming growth factor-β produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int. Immunol. 13: 1147-1154.
7. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347.
8. Curiel, T. J., S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. L. Knutson, B. Daniel, M. C. Zimmermann, et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9: 562-567.
9. + regulatory T cells in human ovarian carcinoma. Cancer Res. 65: 5020-5026.
10. Hartmann, E., B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann. 2003. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63: 6478-6487.
11. + regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118.
12. Yamaguchi, T., and S. Sakaguchi. 2006. Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 16: 115-123.
13. Elenbaas, B., and R. A. Weinberg. 2001. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264: 169-184.
14. Silzle, T., G. J. Randolph, M. Kreutz, and L. A. Kunz-Schughart. 2004. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 108: 173-180.
15. Postlethwaite, A. E., and A. H. Kang. 1999. Fibroblasts and matrix proteins. In Inflammation, Basic Principles and Clinical Correlates. J. I. Gallin, and R. Snyderman, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 227-258.
16. Buckley, C. D., D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22: 199-204.
17. 2 production in human lung fibroblasts. J. Immunol. 160: 1053-1057.
18. Purkerson, J. M., R. S. Smith, S. J. Pollock, and R. P. Phipps. 2005. The TRAF6, but not the TRAF2/3, binding domain of CD40 is required for cytokine production in human lung fibroblasts. Eur. J. Immunol. 35: 2920-2928.
19. Smith, R. S., T. J. Smith, T. M. Blieden, and R. P. Phipps. 1997. Fibroblasts as sentinel cells: synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151: 317-322.
20. Pap, T., U. Muller-Ladner, R. E. Gay, and S. Gay. 2000. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2: 361-367.
21. Hare, K. J., E. J. Jenkinson, and G. Anderson. 1999. In vitro models of T cell development. Semin. Immunol. 11: 3-12.
22. Anderson, G., E. J. Jenkinson, N. C. Moore, and J. J. Owen. 1993. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 362: 70-73.
23. + T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-γ. J. Immunol. 170: 400-412.
24. + effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-γ, and eradicate tumor cells. J. Immunol. 174: 898-906.
25. Iwanuma, Y., F.-A. Chen, N. K. Egilmez, H. Takita, and R. B. Bankert. 1997. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice. Cancer Res. 57: 2937-2942.
26. Fearns, C., and E. B. Dowdle. 1992. The desmoplastic response: induction of collagen synthesis by melanoma cells in vitro. Int. J. Cancer 50: 621-627.
27. Kelynack, K. J., T. D. Hewitson, K. M. Nicholls, I. A. Darby, and G. J. Becker. 2000. Human renal fibroblast contraction of collagen I lattices is an integrin-mediated process. Nephrol. Dial. Transplant. 15: 1766-1772.
28. van Osch, G. J., S. W. van der Veen, W. J. Marijnissen, and J. A. Verhaar. 2001. Monoclonal antibody 11-fibrau: a useful marker to characterize chondrocyte differentiation stage. Biochem. Biophys. Res. Commun. 280: 806-812.
29. Phipps, R. P., D. P. Penney, P. Keng, H. Quill, A. Paxhia, S. Derdak, and M. E. Felch. 1989. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am. J. Respir. Cell Mol. Biol. 1: 65-74.
30. Penney, D. P., P. C. Keng, S. Derdak, and R. P. Phipps. 1992. Morphologic and functional characteristics of subpopulations of murine lung fibroblasts grown in vitro. Anat. Rec. 232: 432-443.
31. McIntosh, J. C., J. S. Hagood, T. L. Richardson, and J. W. Simecka. 1994. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur. Respir. J. 7: 2131-2138.
32. Borrello, M. A., and R. P. Phipps. 1996. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol. 173: 198-206.
33. - human female reproductive tract fibroblasts. Am. J. Physiol. 283: C599-C608.
34. - human female reproductive tract fibroblasts. Am. J. Pathol. 159: 925-935.
35. Baglole, C. J., D. M. Ray, S. H. Bernstein, S. E. Feldon, T. J. Smith, P. J. Sime, and R. P. Phipps. 2006. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol. Invest. 35: 297-325.
36. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
37. Konishi, J., K. Yamazaki, M. Azuma, I. Kinoshita, H. Dosaka-Akita, and M. Nishimura. 2004. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin. Cancer Res. 10: 5094-5100.
38. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
39. Latchman, Y., C. R. Wood, T. Chemova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
40. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chemova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
41. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170: 1257-1266.
42. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
43. Wintterle, S., B. Schreiner, M. Mitsdoerffer, D. Schneider, L. Chen, R. Meyermann, M. Weller, and H. Wiendl. 2003. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 63: 7462-7467.
44. Strome, S. E., H. Dong, H. Tamura, S. G. Voss, D. B. Flies, K. Tamada, D. Salomao, J. Cheville, F. Hirano, W. Lin, et al. 2003. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res. 63: 6501-6505.
45. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123-128.
46. Mouri, H., K. Sakaguchi, T. Sawayama, T. Senoh, T. Ohta, M. Nishimura, A. Fujiwara, M. Terao, Y. Shiratori, and T. Tsuji. 2002. Suppressive effects of transforming growth factor-β1 produced by hepatocellular carcinoma cell lines on interferon-γ production by peripheral blood mononuclear cells. Acta Med. Okayama 56: 309-315.
47. Tada, T., S. Ohzeki, K. Utsumi, H. Takiuchi, M. Muramatsu, X. F. Li, J. Shimizu, H. Fujiwara, and T. Hamaoka. 1991. Transforming growth factor-β-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol. 146: 1077-1082.
48. Dong, H., and L. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81: 281-287.
49. Mazanet, M. M., and C. C. Hughes. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169: 3581-3588.
50. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
51. Ishida, M., Y. Iwai, Y. Tanaka, T. Okazaki, G. J. Freeman, N. Minato, and T. Honjo. 2002. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett. 84: 57-62.
52. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
53. + T cells independent of the PD-1 receptor. J. Exp. Med. 198: 31-38.
54. Mueller, M. M., and N. E. Fusenig. 2004. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4: 839-849.
55. Koumas, L., T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps. 2003. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 163: 1291-1300.
56. Harris, S. G., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150.
57. Mustafa, M., B. Wondimu, M. Bakhiet, and T. Modeer. 2000. Induction of interferon γ in human gingival fibroblasts challenged with phytohaemagglutinin. Cytokine 12: 368-373.
58. + T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am. J. Respir. Crit. Care Med. 162: 1466-1473.
59. Singh, U. P., S. Singh, N. Iqbal, C. T. Weaver, J. R. McGhee, and J. W. Lillard, Jr. 2003. IFN-γ-inducible chemokines enhance adaptive immunity and colitis. J. Interferon Cytokine Res. 23: 591-600.
60. Addison, C. L., D. A. Arenberg, S. B. Morris, Y. Y. Xue, M. D. Burdick, M. S. Mulligan, M. D. Iannettoni, and R. M. Strieter. 2000. The CXC chemokines, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum. Gene Ther. 11: 247-261.
61. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, S. B. Morris, M. D. Burdick, M. C. Glass, D. T. Taub, M. D. Iannettoni, R. I. Whyte, and R. M. Strieter. 1996. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184: 981-992.
62. DeCosse, J. J., C. L. Gossens, J. F. Kuzma, and B. R. Unsworth. 1973. Breast cancer: induction of differentiation by embryonic tissue. Science 181: 1057-1058.
63. DeCosse, J. J., C. Gossens, J. F. Kuzma, and B. R. Unsworth. 1975. Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. J. Natl. Cancer Inst. 54: 913-922.
64. Cooper, M., and H. Pinkus. 1977. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res. 37: 2544-2552.
65. Ronnov-Jessen, L., O. W. Petersen, and M. J. Bissell. 1996. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76: 69-125.
66. Olumi, A. F., G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty, and G. R. Cunha. 1999. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59: 5002-5011.
67. Hayward, S. W., Y. Wang, M. Cao, Y. K. Horn, B. Zhang, G. D. Grossfeld, D. Sudilovsky, and G. R. Cunha. 2001. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 61: 8135-8142.
68. Camps, J. L., S. M. Chang, T. C. Hsu, M. R. Freeman, S. J. Hong, H. E. Zhau, A. C. von Eschenbach, and L. W. Chung. 1990. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA 87: 75-79.
69. Picard, O., Y. Rolland, and M. F. Poupon. 1986. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res. 46: 3290-3294.
70. Gleave, M., J. T. Hsieh, C. A. Gao, A. C. von Eschenbach, and L. W. Chung. 1991. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 51: 3753-3761.
71. Micke, P., and A. Ostman. 2004. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45: S163-S175.